David G. Miller, RPh, on the Drug Quality and Security Act

Published Online: Tuesday, November 12, 2013
Follow Pharmacy_Times:
In this video, David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists (IACP), discusses H.R. 3204, the Drug Quality and Security Act, which passed the House of Representatives on September 25, 2013. Miller explains that IACP opposes the bill because it reaffirms section 503A of the Federal Food, Drug, and Cosmetic Act rather than fixing its problems. This video was recorded at the National Community Pharmacists Association 115th Annual Convention in Orlando.

Related Articles
Starting the New Year can be both exciting and depressing. It’s easy to feel like a failure on January 2 after falling short on a resolution you had set for yourself just 24 hours prior.
Dale Coker, RPh, FIACP, owner/pharmacist of Cherokee Custom Script Pharmacy, in Canton, Ga., has been elected President to the 2015 International Academy of Compounding Pharmacists Board of Directors by the IACP membership. Mr. Coker will serve as President through January 2016.
With patients delivering homemade sweets to your pharmacy counter, how can you ensure that the turkey is the only one stuffed during the holiday season?
To provide further guidance on issues concerning drug compounding, the FDA today announced that experts in pharmacy, pharmaceutical compounding and manufacturing, medicine, and pharmaceutical regulation will comprise the Pharmacy Compounding Advisory Committee.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$